Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Synchronous bilateral Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Indolfi P, Jenkner A, Terenziani M, Crocoli A, Serra A, Collini P, Biasoni D, Gandola L, Bisogno G, Cecchetto G, Di Martino M, D'Angelo P, Bianchi M, Conte M, Inserra A, Pession A, Spreafico F; AIEOP Wilms Tumor Working Group. Indolfi P, et al. Among authors: jenkner a. Cancer. 2013 Apr 15;119(8):1586-92. doi: 10.1002/cncr.27897. Epub 2013 Jan 10. Cancer. 2013. PMID: 23310931 Free article.
Renal cell carcinoma in children: a clinicopathologic study.
Indolfi P, Terenziani M, Casale F, Carli M, Bisogno G, Schiavetti A, Mancini A, Rondelli R, Pession A, Jenkner A, Pierani P, Tamaro P, De Bernardi B, Ferrari A, Santoro N, Giuliano M, Cecchetto G, Piva L, Surico G, Di Tullio MT. Indolfi P, et al. Among authors: jenkner a. J Clin Oncol. 2003 Feb 1;21(3):530-5. doi: 10.1200/JCO.2003.02.072. J Clin Oncol. 2003. PMID: 12560445
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age.
Donfrancesco A, Jenkner A, Castellano A, Ilari I, Milano GM, De Sio L, Cozza R, Fidani P, Deb G, De Laurentis C, Inserra A, Dominici C. Donfrancesco A, et al. Among authors: jenkner a. Acta Paediatr Suppl. 2004 May;93(445):6-11. doi: 10.1111/j.1651-2227.2004.tb03048.x. Acta Paediatr Suppl. 2004. PMID: 15176712 Clinical Trial.
A single-institution Wilms' tumor and localized neuroblastoma series.
Boglino C, Inserra A, Madafferi S, Jenkner A, Diomedi Camassei F, Boldrini R, Donfrancesco A. Boglino C, et al. Among authors: jenkner a. Acta Paediatr Suppl. 2004 May;93(445):74-7. doi: 10.1111/j.1651-2227.2004.tb03062.x. Acta Paediatr Suppl. 2004. PMID: 15176726
Temozolomide in resistant or relapsed pediatric solid tumors.
De Sio L, Milano GM, Castellano A, Jenkner A, Fidani P, Dominici C, Donfrancesco A. De Sio L, et al. Among authors: jenkner a. Pediatr Blood Cancer. 2006 Jul;47(1):30-6. doi: 10.1002/pbc.20516. Pediatr Blood Cancer. 2006. PMID: 16047361 Clinical Trial.
High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
Milano GM, Cozza R, Ilari I, De Sio L, Boldrini R, Jenkner A, De Ioris M, Inserra A, Dominici C, Donfrancesco A. Milano GM, et al. Among authors: jenkner a. Cancer. 2006 Apr 15;106(8):1838-45. doi: 10.1002/cncr.21780. Cancer. 2006. PMID: 16532434 Free article. Clinical Trial.
Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology.
Spreafico F, Bisogno G, Collini P, Jenkner A, Gandola L, D'Angelo P, Casazza G, Piva L, Luksch R, Perotti D, Pession A, Fagioli F, Dallorso S. Spreafico F, et al. Among authors: jenkner a. Pediatr Blood Cancer. 2008 Jul;51(1):23-8. doi: 10.1002/pbc.21524. Pediatr Blood Cancer. 2008. PMID: 18293386 Clinical Trial.
56 results